Myriad Genetics

🔒 Protecting Your Job Search: A Message from Myriad Genetics We have recently been made aware of unauthorized job postings falsely claiming to represent Myriad Genetics. Unfortunately, Myriad is just one of many companies whose identity has been misused by scammers to exploit job seekers. Here are some important reminders: 👉 Myriad Genetics will never request payment, solicit personal financial information, or conduct interviews through informal channels (e.g. via questionnaire, personal e-mail or text messages). 👉 All opportunity-related communication with Myriad Genetics will come from our employees, whose e-mail addresses end with "@myriad.com." We encourage all job seekers to visit our official Careers page below for verified opportunities: https://lnkd.in/grsdsAPB #teamMyriad #jobsearch #cybersecurity

We're honored to be named one of Forbes' Best Mid-Size Employers of 2025! 🎉 This recognition reflects the voices of our teammates and the supportive culture we've built together - one that fosters #innovation, collaboration, and a shared commitment to advancing better health outcomes. We are proud of the incredible teams that make Myriad Genetics a great place to work every day. 💙 Read more about this recognition and see the full list: https://lnkd.in/eEi_edz #companyculture #teamMyriad #bestemployers

New Podcast Episode Alert! 🎙️ In the second episode of the Precision Oncology and Prostate Cancer: The New Standard of Care miniseries, Dr. Paul Sieber and Ashleigh Renitsky, Oncology PA, break down the different types of genetic tests —including gene expression, germline, somatic, and circulating tumor DNA tests— and their roles in prostate cancer management. Don't miss this conversation with oncology experts! https://lnkd.in/gXvq5Zbg #ProstateCancer #GeneticTesting #GeneticInsights #PrecisionMedicine

"One of the things I learned is how many people don't prioritize themselves, especially women and their own health. Moms are working, taking care of kids or taking care of their parents. We tend to take care of everybody else but put ourselves last." - ESPN's Hannah Storm Knowledge is power 💪 when it comes to #breastcancer. Read more of Hannah's story, including the importance of understanding personal risk factors and family health history and how proactive risk assessment makes a difference: https://lnkd.in/gEB_vQHi Learn more about our MyRisk® with RiskScore® Hereditary Cancer Test and how it can help: https://lnkd.in/gtkpWJFr #innovation #genetictesting #cancerawareness

Diagnosis of a rare genetic disease may take up to 4.8 years from symptom onset.* Prenatal screenings can help parents-to-be and their healthcare providers know more about the risk of a genetic condition, sooner. Encourage patients to visit PrenatalScreening.com to learn what screens medical societies recommend and why. #firsttrimester #carrierscreening #cfdnascreening #noninvasiveprenataltesting *Global Genes, Accurate Diagnosis of Rare Diseases Remains Difficult Despite Strong Physician Interest, Published March 6, 2013, Accessed April 19 2024 https:// https://lnkd.in/gFiKCN3J

You know DNA—but do you know Martha Chase? Chase helped unlock one of the biggest scientific breakthroughs of the 20th century: proving that DNA, not proteins, are the molecules responsible for transmitting genetic information. A Cleveland native, Chase earned her bachelor’s degree from The College of Wooster in 1950 before working alongside Albert Hershey on the famous Hershey-Chase experiment. Yet, despite her groundbreaking contributions, history largely overlooked her. When Hershey won the 1969 Nobel Prize, Chase was not mentioned. Still, her work paved the way for discoveries like PGx testing, including the GeneSight® test, which has been taken by more than three million patients. Holly Johnson, Director of Medical Affairs at Myriad Genetics, shares why Chase’s work still matters today and how it influences the work happening in our labs every day. 🔬 Today, we celebrate Martha Chase and all the #WomenInScience who shape the future! 🧬 #InternationalDayofWomenandGirlsinScience #WomenInSTEM #MyriadGenetics

Our teammates are the heart of Myriad Genetics, and we're proud of the culture of #inclusion and the passion they bring to their work - both inside and outside of our organization. As we continue to honor Black History Month, we remain committed to our efforts to advance health and wellness for all. Learn more from our Mental Health team's Michael Starr: #BlackHistoryMonth #mentalhealth #teamMyriad

Early #genetictesting is transforming #prenatal care and empowering parents with critical information to make informed decisions. In this Contemporary OB/GYN interview, Dr. Dallas Reed, MD, FACMG, FACOG, discusses how advancements in screening can improve outcomes while enhancing patient care. 📣 See the full interview: https://lnkd.in/gw4tAzs8 👶 Learn more about our Prequel® Prenatal Screen: https://lnkd.in/giCiw_qe #innovation #patientcare #newparents

🎉 Thrilled to announce that our Women's Health team has been honored with two Gold awards in the Cancer Awareness Advertising Awards! These #awards are in recognition of our recent Breast Cancer Awareness Month campaign, "Getting Ahead of Breast Cancer": 🏆 Pink Ribbon category 🏆 Patient Education Series category These distinctions recognize our ongoing commitment to empower women with the knowledge they need to take charge of their breast health. Thank you to our Women's Health marketing team and our external agency partner, S50, for bringing this impactful campaign to life! See a full list of winners: https://lnkd.in/gPxiwxFf #breastcancer #teamMyriad #breastcancerawareness #patientcare

Today Myriad Genetics, Inc. and Interlink Care Management, Inc. announced an agreement designed to enhance education and access to hereditary cancer testing for CancerCARE for Life members. Read more: https://lnkd.in/gVX_84Gw